Efficacy News and Research

RSS
Tofacitinib shows promise in active ulcerative colitis

Tofacitinib shows promise in active ulcerative colitis

Rivaroxaban effective in children

Rivaroxaban effective in children

Rivaroxaban effective in children

Rivaroxaban effective in children

Tofacitinib drug shows promise against moderate-to-severe ulcerative colitis

Tofacitinib drug shows promise against moderate-to-severe ulcerative colitis

APS’ Sharon S. Keller Chronic Pain Research Program to award $150,000 for eligible members

APS’ Sharon S. Keller Chronic Pain Research Program to award $150,000 for eligible members

Medicago, IDRI receive FDA approval to commence Phase 1 H5N1 vaccine trial

Medicago, IDRI receive FDA approval to commence Phase 1 H5N1 vaccine trial

Combination of exercise and S-nitrosoglutathione improves recovery from stroke

Combination of exercise and S-nitrosoglutathione improves recovery from stroke

Kessler Foundation investigates Ekso's new capabilities for autonomous use by people with SCI

Kessler Foundation investigates Ekso's new capabilities for autonomous use by people with SCI

Trial to test efficacy of NeuRx Diaphragm Pacing System in people with Lou Gehrig's disease

Trial to test efficacy of NeuRx Diaphragm Pacing System in people with Lou Gehrig's disease

Spectrum Pharmaceuticals initiates enrollment in Phase 2b ozarelix study for prostate cancer

Spectrum Pharmaceuticals initiates enrollment in Phase 2b ozarelix study for prostate cancer

Drug-eluting stents cleared for diabetes patients

Drug-eluting stents cleared for diabetes patients

Physiotherapy beneficial for Parkinson’s patients

Physiotherapy beneficial for Parkinson’s patients

Tofacitinib efficacy suggested for rheumatoid arthritis

Tofacitinib efficacy suggested for rheumatoid arthritis

FDA accepts Teva's NDA for Quartette oral contraceptive

FDA accepts Teva's NDA for Quartette oral contraceptive

Wound dressing containing ionic silver capable of killing multidrug-resistant organisms

Wound dressing containing ionic silver capable of killing multidrug-resistant organisms

Epigenetic factors involved in treatment-resistance to schizophrenia drugs

Epigenetic factors involved in treatment-resistance to schizophrenia drugs

Positive results from Acorda post-marketing commitment study of dalfampridine-ER for MS

Positive results from Acorda post-marketing commitment study of dalfampridine-ER for MS

Orally effective FluCide anti-influenza drug candidate

Orally effective FluCide anti-influenza drug candidate

Study assesses gender differences in the efficacy of antiretroviral treatment

Study assesses gender differences in the efficacy of antiretroviral treatment

Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC

Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.